08:28 AM EDT, 09/26/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Thursday that the US Food and Drug Administration has approved the Abbreviated New Drug Application for its Ketoconazole shampoo, 2%, a generic version of the Nizoral anti-dandruff shampoo.
The company also said it has commercially launched the product.
Shares of the company were up 3.6% in recent Thursday premarket activity.
Price: 59.33, Change: +2.05, Percent Change: +3.58